New York approves AI-driven breast cancer diagnostic

New York approves AI-driven breast cancer diagnostic

With Clinical Laboratory Evaluation Program assay validation, the company’s Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples.WHY IT MATTERS
Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible.
“Consistent with our mission of improving healthcare, PDxBr has shown to be an effective prognostic tool to further improve risk stratification over current histopathology methods,” said Wayne Brinster, CEO of PreciseDx, in an announcement.
The company says the AI technology has now proven its ability to enhance invasive breast cancer pathology interpretation with objective, quantifiable and accurate…

Continue Reading
NYU develops health metrics dashboard for all 435 U.S. Congressional Districts

NYU develops health metrics dashboard for all 435 U.S. Congressional Districts

Researchers at New York University Grossman School of Medicine say their new Congressional District Health Dashboard reveals stark geographic, racial and ethnic differences in health across the United States. They hope lawmakers and healthcare organizations can use the tool to better understand and address health inequities.WHY IT MATTERS
Incorporating health measures, such as deaths from cardiovascular disease and breast cancer, along with conditions that affect health like housing affordability and access to nutritious foods, has not been available at the congressional district level.
Offering a single publicly-accessible location, the Congressional District Health Dashboard was built to offer a comprehensive data view of persistent inequities across the…

Continue Reading